Cordio HearO

2020: Release of the application

In the middle of June, 2020 the Israeli startup of Cordio Medical released the Cordio HearO application distinguishing a myocardial infarction on a voice.

The most common symptom of heart failure is short wind because of accumulation of liquid in lungs. Researchers developed a special application which analyzes the user's voice to find out whether it has developments of stagnation connected with heart failure.

Testing of the experimental application took place in Institute of heart of the Jerusalem medical center Hadassav under the leadership of professor Offer Amir, the director of Institute and the consultant of Cordio Medical.

The application distinguishing risk of a heart attack on a voice is released

40 patients who were hospitalized with an acute heart failure and stagnation of lungs participated in a research. Each person used the application to write five offers at receipt and once again before the statement when all developments of stagnation were already stopped. The application with an adequate accuracy distinguished heart failure at all patients.

Developers consider that Cordio HearO can be used by patients with risk of heart failure. They will have to make source recordings of the house during remission. Then they need to make daily entries of the voice which the application will compare to an initial standard. If the application finds out that this patient has a risk of accumulation of liquid in lungs, then will immediately notify the user and his attending physician. Thus, therapy can be appointed even before the patient needs hospitalization.

It not the only solution working by this principle. Scientists from the Singapore hospital Tan Tock Seng and the technology university Nanyang developed the acoustic sensor similar to a stethoscope which patients can connect to the smartphone. He also allows to estimate developments of stagnation in lungs directly at home.^[1]

Notes